

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.25153045 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.25153045 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.25153045 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.25153045 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.25153045 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.25153045 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.03485209 |
| 8 | negative regulation of cell killing (GO:0031342) | 6.03485209 |
| 9 | cellular response to type I interferon (GO:0071357) | 5.84304777 |
| 10 | type I interferon signaling pathway (GO:0060337) | 5.84304777 |
| 11 | response to type I interferon (GO:0034340) | 5.79997178 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 5.65919917 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 5.37660116 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.28835310 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.28835310 |
| 16 | response to interferon-alpha (GO:0035455) | 5.14618360 |
| 17 | response to peptidoglycan (GO:0032494) | 5.03349303 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.98228305 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.85830227 |
| 20 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.85801203 |
| 21 | response to host immune response (GO:0052572) | 4.85801203 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.74891319 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.59173788 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.59080300 |
| 25 | negative regulation of viral genome replication (GO:0045071) | 4.57815185 |
| 26 | regulation of T cell tolerance induction (GO:0002664) | 4.48713566 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 4.37967187 |
| 28 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.35823860 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 4.33574339 |
| 30 | response to host (GO:0075136) | 4.30971604 |
| 31 | response to host defenses (GO:0052200) | 4.30971604 |
| 32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.30971604 |
| 33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.30317084 |
| 34 | positive regulation of type 2 immune response (GO:0002830) | 4.29833821 |
| 35 | positive regulation of interferon-beta production (GO:0032728) | 4.24554311 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.24345404 |
| 37 | regulation of RIG-I signaling pathway (GO:0039535) | 4.19993464 |
| 38 | regulation of tolerance induction (GO:0002643) | 4.19961617 |
| 39 | cellular response to interferon-beta (GO:0035458) | 4.19708198 |
| 40 | response to muramyl dipeptide (GO:0032495) | 4.17992218 |
| 41 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.17298934 |
| 42 | positive regulation of T cell cytokine production (GO:0002726) | 4.13763843 |
| 43 | regulation of regulatory T cell differentiation (GO:0045589) | 4.13095572 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.11446975 |
| 45 | positive regulation of tolerance induction (GO:0002645) | 4.09983101 |
| 46 | cellular response to virus (GO:0098586) | 4.08555746 |
| 47 | neutrophil activation involved in immune response (GO:0002283) | 4.06477945 |
| 48 | positive regulation of interleukin-12 production (GO:0032735) | 4.04662341 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 4.03503269 |
| 50 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.00932329 |
| 51 | natural killer cell mediated immunity (GO:0002228) | 4.00498190 |
| 52 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.00498190 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 4.00248864 |
| 54 | negative T cell selection (GO:0043383) | 3.99437188 |
| 55 | negative thymic T cell selection (GO:0045060) | 3.98270525 |
| 56 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.94954872 |
| 57 | cellular response to interferon-alpha (GO:0035457) | 3.92034660 |
| 58 | detection of other organism (GO:0098543) | 3.91345068 |
| 59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.90850944 |
| 60 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.87418595 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.87156853 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.85791793 |
| 63 | cellular response to exogenous dsRNA (GO:0071360) | 3.83633406 |
| 64 | response to interleukin-15 (GO:0070672) | 3.82583886 |
| 65 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.76797223 |
| 66 | T cell migration (GO:0072678) | 3.75754477 |
| 67 | positive regulation of interleukin-17 production (GO:0032740) | 3.73933056 |
| 68 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.72498064 |
| 69 | detection of external biotic stimulus (GO:0098581) | 3.69531325 |
| 70 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.63576089 |
| 71 | immunoglobulin mediated immune response (GO:0016064) | 3.62683851 |
| 72 | I-kappaB phosphorylation (GO:0007252) | 3.61287725 |
| 73 | microglial cell activation (GO:0001774) | 3.61099227 |
| 74 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.57301181 |
| 75 | defense response to virus (GO:0051607) | 3.53522793 |
| 76 | positive regulation of humoral immune response (GO:0002922) | 3.53004693 |
| 77 | leukocyte aggregation (GO:0070486) | 3.51066501 |
| 78 | detection of bacterium (GO:0016045) | 3.50434385 |
| 79 | cellular response to interleukin-15 (GO:0071350) | 3.50310720 |
| 80 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.50162639 |
| 81 | T-helper 1 type immune response (GO:0042088) | 3.48224133 |
| 82 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.47797413 |
| 83 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.46583176 |
| 84 | cellular response to interferon-gamma (GO:0071346) | 3.45328280 |
| 85 | granulocyte activation (GO:0036230) | 3.45161356 |
| 86 | regulation of antigen processing and presentation (GO:0002577) | 3.43685738 |
| 87 | interferon-gamma production (GO:0032609) | 3.42837643 |
| 88 | response to interferon-beta (GO:0035456) | 3.42773377 |
| 89 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.39417493 |
| 90 | positive regulation of heat generation (GO:0031652) | 3.38978057 |
| 91 | regulation of interleukin-17 production (GO:0032660) | 3.37698798 |
| 92 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.37426441 |
| 93 | myeloid dendritic cell differentiation (GO:0043011) | 3.35638423 |
| 94 | regulation of T cell cytokine production (GO:0002724) | 3.32122830 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.31820316 |
| 96 | regulation of interleukin-12 production (GO:0032655) | 3.30737915 |
| 97 | positive thymic T cell selection (GO:0045059) | 3.29717552 |
| 98 | neutrophil activation (GO:0042119) | 3.29624706 |
| 99 | tolerance induction (GO:0002507) | 3.29461537 |
| 100 | detection of biotic stimulus (GO:0009595) | 3.29232609 |
| 101 | defense response to protozoan (GO:0042832) | 3.28444710 |
| 102 | macrophage activation (GO:0042116) | 3.26580879 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.25630911 |
| 104 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.25533283 |
| 105 | detection of molecule of bacterial origin (GO:0032490) | 3.22366298 |
| 106 | regulation of activation of Janus kinase activity (GO:0010533) | 3.20912111 |
| 107 | positive regulation of response to biotic stimulus (GO:0002833) | 3.18652571 |
| 108 | positive T cell selection (GO:0043368) | 3.17678862 |
| 109 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.16196909 |
| 110 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.15629060 |
| 111 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.15173319 |
| 112 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.13785475 |
| 113 | negative regulation of interleukin-17 production (GO:0032700) | 3.12841388 |
| 114 | modulation by symbiont of host cellular process (GO:0044068) | 3.12517859 |
| 115 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.11347014 |
| 116 | regulation of interferon-beta production (GO:0032648) | 3.10423812 |
| 117 | regulation of fever generation (GO:0031620) | 3.09383403 |
| 118 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.07912487 |
| 119 | interferon-gamma secretion (GO:0072643) | 3.07849352 |
| 120 | positive regulation of defense response to virus by host (GO:0002230) | 3.07481072 |
| 121 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.06602029 |
| 122 | lymphocyte chemotaxis (GO:0048247) | 3.06350725 |
| 123 | myeloid cell activation involved in immune response (GO:0002275) | 3.05790929 |
| 124 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05292451 |
| 125 | activated T cell proliferation (GO:0050798) | 3.05219155 |
| 126 | regulation of immunoglobulin secretion (GO:0051023) | 3.04664450 |
| 127 | negative regulation of interleukin-12 production (GO:0032695) | 3.04551134 |
| 128 | myeloid dendritic cell activation (GO:0001773) | 3.04302508 |
| 129 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.03536060 |
| 130 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03355307 |
| 131 | B cell mediated immunity (GO:0019724) | 3.03034958 |
| 132 | negative regulation of innate immune response (GO:0045824) | 3.02948908 |
| 133 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.02812171 |
| 134 | regulation of gamma-delta T cell activation (GO:0046643) | 3.02671114 |
| 135 | cellular extravasation (GO:0045123) | 3.02569089 |
| 136 | positive regulation of interleukin-10 production (GO:0032733) | 3.02537651 |
| 137 | regulation of defense response to virus by host (GO:0050691) | 3.02420907 |
| 138 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.02341318 |
| 139 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.02341318 |
| 140 | T cell selection (GO:0045058) | 3.01763707 |
| 141 | superoxide anion generation (GO:0042554) | 3.01441288 |
| 142 | response to protozoan (GO:0001562) | 3.01137826 |
| 143 | response to interferon-gamma (GO:0034341) | 2.99983116 |
| 144 | B cell receptor signaling pathway (GO:0050853) | 2.98397050 |
| 145 | myeloid leukocyte mediated immunity (GO:0002444) | 2.95773050 |
| 146 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.95381459 |
| 147 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.93903225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.56688051 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.36279556 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 7.16318785 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.25491149 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.65998555 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.27134386 |
| 7 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.76759485 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56123271 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.38727691 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20710389 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.17696431 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.00443760 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.94445682 |
| 14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.81548130 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57018741 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33973322 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.28279597 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27631994 |
| 19 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.00946781 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84638382 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83850351 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.82103200 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.78792849 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.73716799 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71757970 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60459267 |
| 27 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55610930 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.51887957 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47828364 |
| 30 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47346306 |
| 31 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44820853 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42385236 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42161760 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41770372 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38582332 |
| 36 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38343113 |
| 37 | * MAF_26560356_Chip-Seq_TH1_Human | 1.36967645 |
| 38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34036791 |
| 39 | * MYB_26560356_Chip-Seq_TH1_Human | 1.29645882 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27957035 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24707512 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.22453056 |
| 43 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22335715 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14196436 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11962922 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11521908 |
| 47 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10637152 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10233692 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.09380138 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09337541 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09137605 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07753215 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.07689076 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06724822 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06307360 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05525643 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05518473 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02022617 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99222534 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99218485 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98320858 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95711274 |
| 63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92031245 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91954030 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91336306 |
| 66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.91310524 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89922395 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89400460 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89201620 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89016463 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84138007 |
| 72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84099565 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84093000 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83659407 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80992156 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80507715 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80442944 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80335003 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80330033 |
| 80 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78320080 |
| 81 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75715939 |
| 82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.74968258 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74762987 |
| 84 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74745340 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74740734 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73758158 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.72990813 |
| 88 | UTX_26944678_Chip-Seq_JUKART_Human | 0.70407849 |
| 89 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.70129041 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.69869905 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69603615 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.69073371 |
| 93 | GATA3_26560356_Chip-Seq_TH1_Human | 0.68328324 |
| 94 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.68325871 |
| 95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.68280662 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67973226 |
| 97 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65789842 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64561827 |
| 99 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.63836597 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.63678561 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.63348809 |
| 102 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.63128438 |
| 103 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.63024509 |
| 104 | * MAF_26560356_Chip-Seq_TH2_Human | 0.62954419 |
| 105 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.62674304 |
| 106 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.62610626 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62149078 |
| 108 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.60971637 |
| 109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60963474 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60095610 |
| 111 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.59492067 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.58701324 |
| 113 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.58581922 |
| 114 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.58471303 |
| 115 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.57649945 |
| 116 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.57649945 |
| 117 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.57617955 |
| 118 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.57592852 |
| 119 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.57545431 |
| 120 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.57081006 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56267147 |
| 122 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.56013613 |
| 123 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.55808974 |
| 124 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.55777605 |
| 125 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.55759662 |
| 126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.54810968 |
| 127 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.54810968 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.54394131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.78961153 |
| 2 | MP0009785_altered_susceptibility_to | 4.45757136 |
| 3 | MP0001790_abnormal_immune_system | 3.60957704 |
| 4 | MP0005387_immune_system_phenotype | 3.60957704 |
| 5 | MP0000685_abnormal_immune_system | 3.55063130 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.42637957 |
| 7 | MP0003436_decreased_susceptibility_to | 3.42137567 |
| 8 | MP0004510_myositis | 3.39208067 |
| 9 | MP0006082_CNS_inflammation | 3.36043664 |
| 10 | MP0005025_abnormal_response_to | 3.21042899 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.19373602 |
| 12 | MP0003303_peritoneal_inflammation | 3.18618826 |
| 13 | MP0002419_abnormal_innate_immunity | 2.91240352 |
| 14 | MP0005671_abnormal_response_to | 2.88925374 |
| 15 | MP0003724_increased_susceptibility_to | 2.87317750 |
| 16 | MP0001800_abnormal_humoral_immune | 2.85551082 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.75290467 |
| 18 | MP0002723_abnormal_immune_serum | 2.71736230 |
| 19 | MP0001819_abnormal_immune_cell | 2.32127469 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.24479200 |
| 21 | MP0004947_skin_inflammation | 2.20600644 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.10353798 |
| 23 | MP0009764_decreased_sensitivity_to | 2.10170271 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.08144764 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.88843904 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.86505351 |
| 27 | MP0001853_heart_inflammation | 1.86412720 |
| 28 | MP0002006_tumorigenesis | 1.85096511 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.83652201 |
| 30 | MP0003448_altered_tumor_morphology | 1.82148963 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.78932754 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.75175381 |
| 33 | MP0005451_abnormal_body_composition | 1.73713600 |
| 34 | MP0008469_abnormal_protein_level | 1.73385002 |
| 35 | MP0005310_abnormal_salivary_gland | 1.71446875 |
| 36 | MP0002405_respiratory_system_inflammati | 1.71364231 |
| 37 | MP0000716_abnormal_immune_system | 1.70990465 |
| 38 | MP0008260_abnormal_autophagy | 1.65645541 |
| 39 | MP0002398_abnormal_bone_marrow | 1.64938436 |
| 40 | MP0009278_abnormal_bone_marrow | 1.64852978 |
| 41 | MP0002254_reproductive_system_inflammat | 1.64818956 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.52481506 |
| 43 | MP0004858_abnormal_nervous_system | 1.43352851 |
| 44 | MP0000343_altered_response_to | 1.40769282 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.40533247 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.39642225 |
| 47 | MP0003075_altered_response_to | 1.37541394 |
| 48 | MP0000604_amyloidosis | 1.32661765 |
| 49 | MP0002429_abnormal_blood_cell | 1.31874933 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.31427281 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.31427281 |
| 52 | MP0004883_abnormal_blood_vessel | 1.30361568 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.29436237 |
| 54 | MP0004381_abnormal_hair_follicle | 1.25742757 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.22891786 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.19769525 |
| 57 | MP0010307_abnormal_tumor_latency | 1.18301380 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.17454654 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.15005072 |
| 60 | MP0002722_abnormal_immune_system | 1.14082947 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.12258233 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.12201051 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.11732878 |
| 64 | MP0009763_increased_sensitivity_to | 1.10216151 |
| 65 | MP0002132_abnormal_respiratory_system | 1.08912527 |
| 66 | MP0009840_abnormal_foam_cell | 1.08400387 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.05704504 |
| 68 | MP0003191_abnormal_cellular_cholesterol | 1.02768569 |
| 69 | MP0003091_abnormal_cell_migration | 1.01975817 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00915562 |
| 71 | MP0000858_altered_metastatic_potential | 1.00759624 |
| 72 | MP0003045_fibrosis | 0.95581941 |
| 73 | MP0005166_decreased_susceptibility_to | 0.93765094 |
| 74 | MP0003787_abnormal_imprinting | 0.93349858 |
| 75 | MP0005390_skeleton_phenotype | 0.86903728 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.84351264 |
| 77 | MP0005164_abnormal_response_to | 0.84225945 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.83975382 |
| 79 | MP0003690_abnormal_glial_cell | 0.83837063 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.82913186 |
| 81 | MP0000371_diluted_coat_color | 0.82535182 |
| 82 | MP0001873_stomach_inflammation | 0.82413367 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.79059506 |
| 84 | MP0001663_abnormal_digestive_system | 0.78653430 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.77893098 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.77590494 |
| 87 | MP0003195_calcinosis | 0.75917323 |
| 88 | MP0002163_abnormal_gland_morphology | 0.74324629 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.71172803 |
| 90 | MP0005257_abnormal_intraocular_pressure | 0.70468484 |
| 91 | MP0002933_joint_inflammation | 0.69114412 |
| 92 | MP0001501_abnormal_sleep_pattern | 0.68827184 |
| 93 | MP0000703_abnormal_thymus_morphology | 0.68023220 |
| 94 | MP0003828_pulmonary_edema | 0.67105746 |
| 95 | MP0003646_muscle_fatigue | 0.66478199 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.65729149 |
| 97 | MP0001348_abnormal_lacrimal_gland | 0.65118767 |
| 98 | MP0000249_abnormal_blood_vessel | 0.63937453 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.61583021 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.60143185 |
| 101 | MP0001851_eye_inflammation | 0.59589972 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.59432380 |
| 103 | MP0000490_abnormal_crypts_of | 0.58832046 |
| 104 | MP0006054_spinal_hemorrhage | 0.57720810 |
| 105 | MP0008874_decreased_physiological_sensi | 0.57474503 |
| 106 | MP0001881_abnormal_mammary_gland | 0.57144966 |
| 107 | MP0008873_increased_physiological_sensi | 0.55890644 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.55825196 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.54887681 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.54263085 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.53068657 |
| 112 | MP0002396_abnormal_hematopoietic_system | 0.51190602 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.49999317 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.49954084 |
| 115 | MP0008004_abnormal_stomach_pH | 0.49768169 |
| 116 | MP0000383_abnormal_hair_follicle | 0.49535981 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.48233610 |
| 118 | MP0003795_abnormal_bone_structure | 0.47836501 |
| 119 | MP0003866_abnormal_defecation | 0.47082242 |
| 120 | MP0003186_abnormal_redox_activity | 0.46954705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.04479552 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.03453843 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.75888391 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.23951333 |
| 5 | Optic neuritis (HP:0100653) | 5.23951333 |
| 6 | Orchitis (HP:0100796) | 5.15683375 |
| 7 | Chronic otitis media (HP:0000389) | 4.99778279 |
| 8 | Myositis (HP:0100614) | 4.96783216 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.94987110 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.93824394 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.72066104 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 4.71052524 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.70305269 |
| 14 | Increased IgM level (HP:0003496) | 4.55280614 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.29510926 |
| 16 | Recurrent viral infections (HP:0004429) | 4.28301982 |
| 17 | Vasculitis (HP:0002633) | 4.22537908 |
| 18 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.15055389 |
| 19 | Basal ganglia calcification (HP:0002135) | 4.00291800 |
| 20 | Recurrent skin infections (HP:0001581) | 3.94612895 |
| 21 | Stomatitis (HP:0010280) | 3.90214048 |
| 22 | Gingivitis (HP:0000230) | 3.77741353 |
| 23 | Nasal polyposis (HP:0100582) | 3.64879362 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.60489871 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.60489871 |
| 26 | Porencephaly (HP:0002132) | 3.57213247 |
| 27 | Pulmonary infiltrates (HP:0002113) | 3.54816130 |
| 28 | Prostate neoplasm (HP:0100787) | 3.48658974 |
| 29 | Hypergammaglobulinemia (HP:0010702) | 3.38769348 |
| 30 | Peritonitis (HP:0002586) | 3.33079689 |
| 31 | Premature loss of primary teeth (HP:0006323) | 3.27503843 |
| 32 | Periodontitis (HP:0000704) | 3.22138401 |
| 33 | Abnormality of the nasal mucosa (HP:0000433) | 3.17352394 |
| 34 | Tetraparesis (HP:0002273) | 3.04993026 |
| 35 | Arterial thrombosis (HP:0004420) | 3.03435558 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.00320175 |
| 37 | Obstructive lung disease (HP:0006536) | 3.00320175 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 2.99160311 |
| 39 | Recurrent bronchitis (HP:0002837) | 2.98134461 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 2.95821113 |
| 41 | Keratoconjunctivitis sicca (HP:0001097) | 2.93883136 |
| 42 | Vacuolated lymphocytes (HP:0001922) | 2.92013980 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.85806590 |
| 44 | Hemoptysis (HP:0002105) | 2.85751144 |
| 45 | Pulmonary embolism (HP:0002204) | 2.85190693 |
| 46 | Chronic sinusitis (HP:0011109) | 2.84524396 |
| 47 | Thick nail (HP:0001805) | 2.81348334 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.78774856 |
| 49 | Pustule (HP:0200039) | 2.77711336 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.72602368 |
| 51 | Gastrointestinal infarctions (HP:0005244) | 2.64231452 |
| 52 | Gingival bleeding (HP:0000225) | 2.63820119 |
| 53 | Meningitis (HP:0001287) | 2.63699146 |
| 54 | IgG deficiency (HP:0004315) | 2.63308171 |
| 55 | Acute hepatic failure (HP:0006554) | 2.62745667 |
| 56 | Leukocytosis (HP:0001974) | 2.58146008 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.55865215 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.52331259 |
| 59 | Cellulitis (HP:0100658) | 2.47091117 |
| 60 | Cleft eyelid (HP:0000625) | 2.46623080 |
| 61 | Osteomyelitis (HP:0002754) | 2.46056145 |
| 62 | Joint swelling (HP:0001386) | 2.42503194 |
| 63 | Recurrent pneumonia (HP:0006532) | 2.39619130 |
| 64 | Myocardial infarction (HP:0001658) | 2.39241498 |
| 65 | Anorexia (HP:0002039) | 2.39121474 |
| 66 | Eosinophilia (HP:0001880) | 2.39061528 |
| 67 | Plagiocephaly (HP:0001357) | 2.38369635 |
| 68 | Increased IgE level (HP:0003212) | 2.37004234 |
| 69 | Episodic fever (HP:0001954) | 2.34222069 |
| 70 | Keratitis (HP:0000491) | 2.33906316 |
| 71 | Epistaxis (HP:0000421) | 2.32864831 |
| 72 | Glomerulopathy (HP:0100820) | 2.31458026 |
| 73 | Abnormality of the peritoneum (HP:0002585) | 2.29933678 |
| 74 | Abnormality of T cell number (HP:0011839) | 2.29406387 |
| 75 | Colitis (HP:0002583) | 2.28893199 |
| 76 | Slow saccadic eye movements (HP:0000514) | 2.24932478 |
| 77 | Urticaria (HP:0001025) | 2.23555504 |
| 78 | Recurrent lower respiratory tract infections (HP:0002783) | 2.23322625 |
| 79 | Cheilitis (HP:0100825) | 2.22820599 |
| 80 | Autoimmune hemolytic anemia (HP:0001890) | 2.22645990 |
| 81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.22315933 |
| 82 | Amaurosis fugax (HP:0100576) | 2.22288066 |
| 83 | Loss of speech (HP:0002371) | 2.22265840 |
| 84 | Emphysema (HP:0002097) | 2.21732793 |
| 85 | Abnormality of B cell number (HP:0010975) | 2.20244423 |
| 86 | Severe combined immunodeficiency (HP:0004430) | 2.18831984 |
| 87 | Bone pain (HP:0002653) | 2.18626693 |
| 88 | Hematochezia (HP:0002573) | 2.18030490 |
| 89 | Polyneuropathy (HP:0001271) | 2.15659530 |
| 90 | Agammaglobulinemia (HP:0004432) | 2.15024041 |
| 91 | Lymphopenia (HP:0001888) | 2.14836575 |
| 92 | Vertigo (HP:0002321) | 2.14119157 |
| 93 | Abnormality of the prostate (HP:0008775) | 2.12629665 |
| 94 | Hypochromic anemia (HP:0001931) | 2.12374143 |
| 95 | Abnormality of the pericardium (HP:0001697) | 2.09870853 |
| 96 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.08446512 |
| 97 | Prolonged bleeding time (HP:0003010) | 2.07935797 |
| 98 | Thrombophlebitis (HP:0004418) | 2.07760506 |
| 99 | IgA deficiency (HP:0002720) | 2.06159113 |
| 100 | Encephalitis (HP:0002383) | 2.05850786 |
| 101 | Panhypogammaglobulinemia (HP:0003139) | 2.05611984 |
| 102 | Amyloidosis (HP:0011034) | 2.04404921 |
| 103 | Inflammation of the large intestine (HP:0002037) | 2.03957206 |
| 104 | Alveolar cell carcinoma (HP:0006519) | 2.03250679 |
| 105 | Chronic diarrhea (HP:0002028) | 2.02569168 |
| 106 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02284379 |
| 107 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02284379 |
| 108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02284379 |
| 109 | Arthralgia (HP:0002829) | 2.01049706 |
| 110 | Gangrene (HP:0100758) | 2.00555329 |
| 111 | Abnormality of the pleura (HP:0002103) | 1.99853883 |
| 112 | Abnormality of the endocardium (HP:0004306) | 1.98159925 |
| 113 | Axonal loss (HP:0003447) | 1.97195459 |
| 114 | Abnormality of T cells (HP:0002843) | 1.96467540 |
| 115 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96213368 |
| 116 | Abnormality of T cell physiology (HP:0011840) | 1.94839148 |
| 117 | Chest pain (HP:0100749) | 1.93686383 |
| 118 | Acne (HP:0001061) | 1.92620496 |
| 119 | T lymphocytopenia (HP:0005403) | 1.92579400 |
| 120 | Skin ulcer (HP:0200042) | 1.92492365 |
| 121 | Viral hepatitis (HP:0006562) | 1.91536160 |
| 122 | Skin rash (HP:0000988) | 1.91345784 |
| 123 | Granulocytopenia (HP:0001913) | 1.90756807 |
| 124 | Spastic tetraparesis (HP:0001285) | 1.89023500 |
| 125 | Subacute progressive viral hepatitis (HP:0006572) | 1.87835874 |
| 126 | Thyroiditis (HP:0100646) | 1.87134178 |
| 127 | Abnormality of eosinophils (HP:0001879) | 1.86670383 |
| 128 | Frequent falls (HP:0002359) | 1.85010730 |
| 129 | Gastrointestinal inflammation (HP:0004386) | 1.85006313 |
| 130 | Stomach cancer (HP:0012126) | 1.83712263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.91107798 |
| 2 | TYK2 | 4.67702514 |
| 3 | IKBKE | 4.00809532 |
| 4 | TBK1 | 3.76795396 |
| 5 | JAK3 | 3.39062004 |
| 6 | IRAK3 | 3.38977917 |
| 7 | JAK1 | 3.37092297 |
| 8 | IRAK4 | 3.05233592 |
| 9 | RIPK4 | 3.03757308 |
| 10 | MAP3K13 | 2.98020931 |
| 11 | BLK | 2.80291744 |
| 12 | IKBKB | 2.61616187 |
| 13 | TXK | 2.51225421 |
| 14 | KIT | 2.45187403 |
| 15 | PBK | 2.33593447 |
| 16 | MAP4K1 | 2.27069554 |
| 17 | FGFR4 | 2.22296932 |
| 18 | MAP2K3 | 1.87101331 |
| 19 | GRK6 | 1.83165806 |
| 20 | CHUK | 1.82704544 |
| 21 | EIF2AK2 | 1.64908643 |
| 22 | FGFR3 | 1.55466233 |
| 23 | ERN1 | 1.54496147 |
| 24 | PIM2 | 1.50454315 |
| 25 | CSK | 1.41251108 |
| 26 | EPHB1 | 1.38797451 |
| 27 | IRAK1 | 1.31292514 |
| 28 | EPHA3 | 1.30790685 |
| 29 | SYK | 1.26589078 |
| 30 | HCK | 1.22027333 |
| 31 | CDK12 | 1.18571848 |
| 32 | SIK3 | 1.18205354 |
| 33 | ZAP70 | 1.17216403 |
| 34 | TNK2 | 1.16568709 |
| 35 | FGR | 1.14893295 |
| 36 | LCK | 1.06990103 |
| 37 | CSF1R | 1.03842707 |
| 38 | JAK2 | 1.03221364 |
| 39 | MAP3K3 | 1.02081967 |
| 40 | BMPR2 | 0.94274746 |
| 41 | MARK3 | 0.93867018 |
| 42 | SIK2 | 0.92943361 |
| 43 | RPS6KA4 | 0.90201787 |
| 44 | PIM1 | 0.90003486 |
| 45 | IRAK2 | 0.89436004 |
| 46 | TAOK3 | 0.89262769 |
| 47 | MAP3K5 | 0.87321545 |
| 48 | LYN | 0.86007980 |
| 49 | TAOK1 | 0.84417822 |
| 50 | MAP3K11 | 0.83361181 |
| 51 | STK4 | 0.82226478 |
| 52 | MATK | 0.81322178 |
| 53 | LRRK2 | 0.79873971 |
| 54 | BMX | 0.79007430 |
| 55 | PIK3CG | 0.76216497 |
| 56 | FES | 0.75790683 |
| 57 | CDC42BPA | 0.73311175 |
| 58 | BTK | 0.68508164 |
| 59 | MST4 | 0.65485071 |
| 60 | TAOK2 | 0.63867270 |
| 61 | NEK9 | 0.61948815 |
| 62 | CLK1 | 0.59729277 |
| 63 | EGFR | 0.59411821 |
| 64 | PTK2B | 0.58853059 |
| 65 | CAMKK2 | 0.58624629 |
| 66 | YES1 | 0.58251071 |
| 67 | TEC | 0.58124110 |
| 68 | PKN1 | 0.57658391 |
| 69 | SGK2 | 0.56109600 |
| 70 | KSR2 | 0.56046814 |
| 71 | MAP3K10 | 0.55285818 |
| 72 | MAP3K2 | 0.54751162 |
| 73 | ABL1 | 0.52868196 |
| 74 | ADRBK2 | 0.52292682 |
| 75 | STK3 | 0.52031144 |
| 76 | PRKCQ | 0.51275829 |
| 77 | MARK2 | 0.49650216 |
| 78 | CAMK1D | 0.49501276 |
| 79 | NLK | 0.49029933 |
| 80 | PRKCD | 0.46950911 |
| 81 | SIK1 | 0.45745569 |
| 82 | GRK5 | 0.45696610 |
| 83 | MAP2K6 | 0.45560976 |
| 84 | DAPK2 | 0.45544484 |
| 85 | CDK4 | 0.45307404 |
| 86 | WNK1 | 0.44762970 |
| 87 | STK10 | 0.39318443 |
| 88 | TESK2 | 0.38187580 |
| 89 | MAP3K6 | 0.37662855 |
| 90 | TYRO3 | 0.37342793 |
| 91 | TRPM7 | 0.37326464 |
| 92 | TGFBR2 | 0.37289799 |
| 93 | KSR1 | 0.37212563 |
| 94 | ACVR1B | 0.35849637 |
| 95 | ITK | 0.34954513 |
| 96 | GRK7 | 0.34480444 |
| 97 | PTK6 | 0.34008648 |
| 98 | SGK1 | 0.33734929 |
| 99 | FRK | 0.33289612 |
| 100 | RPS6KA5 | 0.33159269 |
| 101 | TTN | 0.31572283 |
| 102 | DAPK3 | 0.31360816 |
| 103 | RIPK1 | 0.29911617 |
| 104 | MST1R | 0.29754191 |
| 105 | RAF1 | 0.29747242 |
| 106 | RET | 0.28488176 |
| 107 | MAPK7 | 0.27784042 |
| 108 | ERBB2 | 0.27563044 |
| 109 | NME2 | 0.27312020 |
| 110 | NUAK1 | 0.26677226 |
| 111 | SGK3 | 0.25703854 |
| 112 | PDGFRB | 0.25682976 |
| 113 | INSRR | 0.25290666 |
| 114 | MAP3K7 | 0.24999515 |
| 115 | STK11 | 0.24968748 |
| 116 | PRKAA2 | 0.24934536 |
| 117 | TNIK | 0.24088720 |
| 118 | CDK6 | 0.23935371 |
| 119 | ABL2 | 0.23143926 |
| 120 | MAPK11 | 0.22719095 |
| 121 | INSR | 0.20210206 |
| 122 | MAPKAPK2 | 0.19897278 |
| 123 | PRPF4B | 0.19371658 |
| 124 | FYN | 0.18981659 |
| 125 | IGF1R | 0.17984836 |
| 126 | ARAF | 0.17440409 |
| 127 | PDK1 | 0.15401622 |
| 128 | MOS | 0.14714983 |
| 129 | SRC | 0.13538822 |
| 130 | HIPK2 | 0.13500841 |
| 131 | MAP3K1 | 0.13297665 |
| 132 | CAMK1G | 0.13119977 |
| 133 | PRKG2 | 0.11914046 |
| 134 | PDPK1 | 0.11759385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.17142285 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.10314515 |
| 3 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.09306036 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.05912567 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.05012670 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.04486584 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.01999973 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.80630779 |
| 9 | Influenza A_Homo sapiens_hsa05164 | 2.53166887 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.47836456 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.38368615 |
| 12 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.23599372 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18642706 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.16754435 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16137426 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.15535432 |
| 17 | Malaria_Homo sapiens_hsa05144 | 2.10068174 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 2.01146120 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.98893589 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.95917462 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.93171155 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.91240506 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.90209424 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.76911295 |
| 25 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.74570237 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69940646 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.64665868 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59185460 |
| 29 | Hepatitis C_Homo sapiens_hsa05160 | 1.58573683 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45081464 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43769254 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39525371 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39524848 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.36860881 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.29678200 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29630632 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28140624 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22392564 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.20185958 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18791640 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.10188852 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.08147749 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01957542 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97998325 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 0.96517129 |
| 46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96307928 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94693910 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93931803 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93339840 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85580242 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80532087 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77626234 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76443541 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73561394 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72965214 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.71472564 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70574968 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62166894 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61571137 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56149417 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56021422 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55875763 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53643173 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51533692 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49978735 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48089024 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47773713 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46406507 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44574229 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43782509 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43213347 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42161559 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41411396 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.41091540 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40325840 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39628578 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39624638 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39448936 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.38307610 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38009643 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34642601 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34393076 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.34098854 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.33508666 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33006410 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32704257 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32137198 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30688445 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29892308 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28955443 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.28817477 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24844850 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24287792 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24052606 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24005389 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22393798 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.21154602 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20680212 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.20426867 |
| 100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20407353 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20212866 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20102698 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18028181 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17749617 |
| 105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.17626996 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.16256973 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16164509 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15147888 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14766399 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.12546922 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.09072549 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.08278479 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.07225361 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.06422571 |

